Verywell Health

Two studies found that Zepbound, an anti-obesity medication, may effectively treat obstructive sleep apnea. Drug manufacturer Eli Lilly has applied to the FDA to market Zepbound for obstructive sleep apnea, with a decision expected by the end of the year. If approved, Zepbound would be the first drug for obstructive...

Anti-Obesity Drug Zepbound May Help Treat Some Forms of Sleep Apnea

If GLP-1 drugs are approved to treat sleep apnea, insurers and employers may be more likely to cover the cost, the Wall Street Journal reported July 16. Eli Lilly, which manufactures Zepbound, said it plans to seek wider approval for the drug after studies showed it could alleviate symptoms of sleep apnea.

Sleep apnea could be key to payer coverage of weight loss drugs

(Reuters) -Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under...

Pfizer Moves Forward With Once-Daily Weight-Loss Pill

Everyday Health

Now in clinical trials, this new medication can lead to impressive weight loss while preserving more lean muscle than its rivals.

Is This Drug the Next Ozempic?

Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic, a head-to-head study published Monday showed.  Most patients achieved five percent or greater weight loss after a year, but those on Mounjaro were more likely to lose weight and achieved greater weight loss. 

Eli Lilly weight loss drug beats Ozempic in head-to-head study

Metformin, a medication commonly used to treat type 2 diabetes, helps the body regulate sugar in the bloodstream. Part of the class of drugs known as biguanides, metformin reduces the amount of sugar you absorb from food and the amount produced by the liver. Metformin also impacts the way the body will respond to insulin, the natural substance that regulates blood sugar levels.

Diabetes Drug Metformin Investigated for Cancer Prevention Use

Factors such as age, sex, and family history can impact a person’s risk of getting pancreatic cancer. It is more likely to occur later in life. Certain conditions can also increase the likelihood of pancreatic cancer. Pancreatic cancer develops in the tissues of the pancreas. This organ secretes digestive...

Who is most likely to get pancreatic cancer?

Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, typically in the legs. Treating a DVT is crucial, as the clot can break loose from the affected vein, move through the bloodstream to the heart, and lodge itself within the lung's main artery. This complication—what's known as pulmonary embolism—can be fatal.

How to Dissolve Blood Clots in Legs

(HealthDay News) — Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia. Cong Xie, PhD, from the University of Adelaide in Australia, and colleagues studied 16 participants with type...

Timing of metformin important in metformin-treated type 2 diabetes

Study shows patients 80 years and older with atrial fibrillation treated with a lower dose of edoxaban experienced fewer major gastrointestinal bleeding events for each additional ischemic stroke. Patients aged 80 years and above with atrial fibrillation (AF) may gain a benefit from treatment with lower-dose anticoagulants regardless of existing...

Phase III Trial Shows Older Patients with Atrial Fibrillation May Benefit From Lower-Dose Anticoagulants

Patients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses, according to a study published online June 6 in Blood Advances. Gualtiero Palareti, M.D., from Fondazione Arianna Anticoagulazione in Bologna, Italy, and colleagues collected venous blood at 15...

Low Dose Direct Oral Anticoagulants in Patients With Atrial Fibrillation Tied to Higher Bleeding Incidence vs Standard Doses

Because heartburn (acid reflux) can cause chest pain, knowing the difference between heartburn and a heart attack can be challenging. A heart attack (myocardial infarction) is a medical emergency that occurs when blood flow to the heart muscle is reduced or blocked. One of the symptoms of a heart attack...

Am I Having Heartburn or a Heart Attack?

'Mad Money' host Jim Cramer talks about the state of the consumer and historic trends he is seeing in the economy.

Inflation has left people in 'a really bad way', says Jim Cramer

Chronic obstructive pulmonary disease (COPD) significantly heightens the risk of mortality and hospitalization in patients with heart failure with preserved ejection fraction (HFpEF). Chronic obstructive pulmonary disease (COPD) significantly increases the risk of long-term all-cause mortality and hospitalization among patients with heart failure with preserved ejection fraction (HFpEF), according to...

COPD Linked to Increased Mortality, Hospitalization Risk in Patients With HFpEF

Health

Reviewed by Ivy Kwong, LMFTReviewed by Ivy Kwong, LMFTIrritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two chronic gastrointestinal disorders that share some overlapping symptoms, like abdominal pain, bloating, and diarrhea. While IBS and IBD have similar symptoms and acronyms, they are two distinct conditions with different underlying causes and treatment approaches. IBS is a functional disorder, meaning it affects how the intestines work but doesn't cause inflammation. IBD is an inflammatory disease that damages the gastrointestinal (GI) tract. In the United States, IBS affects between 25-45 million people, and IBD affects more than 3 million people.Symptoms of IBS vs....

What Is the Difference Between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)?

Denver, CO

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

David Heitz

A dangerous drug that is being mixed into fentanyl is causing those who inject it to develop a rash of sores that resembles a case of flesh-eating bacteria. People experiencing homelessness around Denver can sometimes be seen with these bloody, weeping wounds. I recently mentioned this phenomenon to a fentanyl user who told me about the xylazine connection.

Denver homeless people suffer sores as xylazine enters fentanyl supply

New York Post

Can Ozempic help cure arthritis? Some doctors say so. 

Many overweight patients struggle with chronic conditions like high blood pressure, fatty liver, rheumatoid arthritis, and sleep apnea. 

Now, some doctors are suggesting an “obesity first” approach to treating these issues. 

The idea is to treat obesity with medications approved for that use and, as weight drops, other chronic diseases will also improve or go away altogether. 

By prescribing a drug such as Wegovy from Novo Nordisk or Zepbound from Eli Lilly, in addition to diet and exercise, doctors are confident they can treat obesity and improve related conditions with a...

Ozempic to treat arthritis? Why doctors say obesity drugs could cure a host of chronic illnesses

rolling out

Aspirin is a familiar name in most households, often associated with pain relief and fever reduction. However, aspirin is crucial to heart health beyond these common uses. Doctors frequently prescribe low-dose aspirin for people with existing heart disease or those at high risk of developing it. This article explores the science behind aspirin’s heart-protective benefits and circumstances where it might be recommended.

Why doctors prescribe aspirin to heart patients

San Diego, CA

Researchers at University of California San Diego School of Medicine and international collaborators have led a global study demonstrating the potential of tirzepatide, a drug known to manage type 2 diabetes, as the first effective drug therapy for obstructive sleep apnea (OSA) in patients diagnosed with obesity. The results, published in the June 21, 2024 online edition of New England Journal of Medicine, highlight the treatment’s potential to improve the quality of life for millions worldwide affected by OSA.

Diabetes Drug Tirzepatide Shows Promise as First Effective Therapy for Sleep Apnea in Obese Patients

T3D reveals a significant relationship between brain dysfunction and glucose levels, a critical factor in AD. Insufficient glucose levels can lead to an aggressive decline in insight, judgment, memory, and reasoning. Limited research reveals a link between Alzheimer’s disease and type 2 diabetes. Additional research is needed to understand...

What Is Type 3 Diabetes?

NewsBreak

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

Eli Lilly said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects...

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

Comments / 0